Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-459-7
CAS number: 107-07-3
2-Chloroethanol is not carcinogenic.
Based on the available data, the test item is not subject to C&L
according to Directive 67/548/EEC or the Regulation 1272/2008/EC.
It could be concluded that a 2 years dermal dose of up to 100 mg/kg
bw/day 2 -chloroethanol has no adverse effects in rats.
In the second key study (NTP, (1985)) carcinogenicity of 2
-chloroethanol after dermal exposure was investigated in mice. 50 Swiss
CD-1 mice per dose per sex received 0, 7.5, 15 mg/mouse once daily 5
days per week for 104 weeks (0, 253, or 630 mg/kg bw/day at week 1; 0,
180, or 411 mg/kg bw/day at week 100). Beside the vehicle control also
untreated controls (50/sex) were available for evaluation. No
treatment-related clinical signs were found in any group and only slight
effects on body weight. Survival was significantly reduced in high dose
males which died during the first week of application with local effects
at the site of application and pathological alterations in the lung. No
carcinogenic effects were detected. In summary, no adverse effects in
female mice exposed for 2 years to dermal doses of up to 15 mg/mouse/day
could be observed, but adverse effects in male mice at this dose level;
the NOAEL in males was 7.5 mg/mouse/day. 2 -Chloroethanol provided no
carcinogenic activity in male and female mice.
In a carcinogenicity study by Dunkelberg et al., (1983), twice weekly
oral applications of dose levels up to 10 mg/kg bw via gavage for 150
weeks did not result in toxic or carcinogenic effects in female rats. In
female NMRI mice, investigated as second species, no local or systemic
carcinogenic effects were detected after weekly s.c. injection of doses
up to 3 mg/mouse (50 -90 mg/kg bw/injection).
In an insufficiently reported study (Mason et al., (1971) no
carcinogenic activity was detected in male and female F344 rats after
s.c. injection (2 times per week for 1 year) of doses up to 10 mg/kg
In two studies with transgenic mice (Tennant et al., 1996;
Spalding et al., 1999) after dermal application of 2
-chloroethanol no increased skin tumor incidence could be observed. In a
furhter carcinogenicity study (Nin et al., 1969) single s.c. injection
of newborn mice at dose levels up to 0.17 mg/animal did not induce
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again